Business · 07/08/2013

FDA Releases Guidance for Industry on Oversight of Clinical Investigations

The Food and Drug Administration (FDA) has made available a new guidance document that provides industry sponsors with a risk-based approach to monitoring clinical investigations of human drugs, biologics, and medical devices, aiming to enhance human subject protection and data quality.